Schedule 13D ownership disclosure

Amneal Pharmaceuticals Inc

Class A Common Stock, par value $0.01 · CUSIP: 03168L105

Event date: 2025-10-03

Filing-level shares
23,828,992
Percent of class
7.6%
  • Patel DipanReported CIK 0001745437

    Shares: 23,828,992 · Class: 7.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000898432-25-000785
Form type
SCHEDULE 13D/A
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Oct 06, 2025
Reporting period
Oct 03, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub